Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros®
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros®
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2026
2025
2024
2023
2022
2025
2025-07-21 08:00
Prolight secures patent in Japan for Psyros™ technology
2025-07-15 14:00
Last day of trading in BTAs – conversion of BTAs into shares
Regulatory
2025-07-02 08:05
Prolight’s rights issue fully subscribed
Regulatory
MAR
2025-06-30 17:50
Prolight announces preliminary outcome of the rights issue
Regulatory
MAR
2025-06-30 14:40
Annual general meeting of Prolight Diagnostics AB (publ) on 30 June 2025
Regulatory
2025-06-27 08:00
Prolight Diagnostics showcases Psyros™ at ADLM 2025 in Chicago
2025-06-25 08:00
The last day of trading in subscription rights in Prolight’s rights issue
Regulatory
2025-06-23 19:00
Prolight announces additional subscription commitments from the board, management and existing shareholders
2025-06-19 09:30
Prolight announces appointment of Professor Matt Reed to Clinical Advisory Board
2025-06-18 08:15
Emergers publishes updated analysis for Prolight Diagnostics
Previous
Next
